{"input_url":"https://oncodaily.com/oncolibrary/immune-oncology/artificial-intelligence","gnews_decode":"https://oncodaily.com/oncolibrary/immune-oncology/artificial-intelligence","http_status":200,"final_url":"https://oncodaily.com/oncolibrary/immune-oncology/artificial-intelligence","html_length":175371,"trafilatura_result":"ok","text_length":22217,"text_preview":"Cancer immunotherapy has redefined the treatment of many solid and hematologic malignancies, offering durable responses that were once considered impossible. Yet one of its greatest challenges remains unchanged: not every patient benefits from treatment. While some patients experience long-term dise","verdict":"OK"}